Notice2025-03845
Tiered Pharmacy Copayments for Medications; Calendar Year 2025 Update
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 11, 2025
Issuing agencies
Veterans Affairs Department
Abstract
This Department of Veterans Affairs (VA) notice updates the information on Tier 1 medications.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 46 (Tuesday, March 11, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 46 (Tuesday, March 11, 2025)]
[Notices]
[Pages 11777-11778]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-03845]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Tiered Pharmacy Copayments for Medications; Calendar Year 2025
Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Tamara Wagner, Management Analyst,
Office of Finance/Revenue Operations, Veterans Health Administration,
Department of Veterans Affairs, 128 Bingham Road, Suite 1000,
Asheville, NC 28806; telephone 970-242-0731, extension 2219. (This is
not a toll-free telephone number.)
SUPPLEMENTARY INFORMATION: Section 17.110 of title 38, Code of Federal
Regulations (CFR), governs copayments for medications that VA provides
to veterans. Section 17.110 provides the methodologies for establishing
the copayment amount for each 30-day or less supply of medication
provided by VA on an outpatient basis (other than medication
administered during treatment).
Tier 1 medication means a multi-source medication that has been
identified using the process described in 38 CFR
17.110(b)(1)(iv)(A)(1)(i) and (ii). Not less than once per year, VA
will identify a subset of multi-source medications as Tier 1
medications. Only medications that meet all the criteria in 38 CFR
17.110(b)(2)(i), (ii), and (iii) will be eligible to be considered Tier
1 medications, and only those medications that meet all the criteria in
38 CFR 17.110(b)(2)(i) will be assessed using the criteria in
paragraphs (b)(2)(ii) and (iii).
Based on the methodologies set forth in Sec. 17.110, this notice
updates the list of Tier 1 medications for Calendar Year 2025. The Tier
1 medication list is posted on VA's website at the following link:
<a href="https://www.va.gov/resources/va-tier-1-copay-medication-list/">https://www.va.gov/resources/va-tier-1-copay-medication-list/</a>.
The following table is the Tier 1 Copay Medication List that is
effective
January 1, 2025, and will remain in effect until December 31, 2025.
------------------------------------------------------------------------
Condition VA product name
------------------------------------------------------------------------
Arthritis and Pain................ Aspirin buffered tablet, Aspirin
chewable tablet, Aspirin enteric
coated tablet, Allopurinol tablet,
Celecoxib capsule, Diclofenac
tablet, Ibuprofen tablet, Meloxicam
tablet, Naproxen tablet.
Blood Thinners and Platelet Clopidogrel Bisulfate tablet.
Inhibitors.
Cholesterol....................... Atorvastatin tablet, Ezetimibe
tablet, Fenofibrate capsule or
tablet, Pravastatin tablet,
Rosuvastatin Calcium (CA) tablet,
Simvastatin tablet.
Dementia.......................... Donepezil tablet.
Diabetes.......................... Glipizide tablet, Metformin
Hydrochloride HCL tablet, Metformin
HCL 24-hour Sustained Action (SA)
tablet, Pioglitazone HCL tablet.
Electrolyte Supplement............ Potassium SA tablet, Potassium SA
dispersible tablet.
Gastrointestinal Health........... Famotidine tablet, Omeprazole
Enteric-Coated (EC) capsule,
Pantoprazole Sodium capsule.
Glaucoma and Eye Care............. Carboxymethylcellulose Sodium
solution, Diclofenac solution,
Latanoprost 0.005% solution,
Polyethylene Glycol Solution.
[[Page 11778]]
Heart Health and Blood Pressure... Amiodarone tablet, Amlodipine
tablet, Aspirin (see Arthritis &
Pain), Atenolol tablet, Carvedilol
tablet, Chlorthalidone tablet,
Clonidine tablet, Diltiazem 24-hour
capsule, Diltiazem HCL tablet,
Furosemide tablet, Hydralazine HCL
tablet, Hydrochlorothiazide tablet/
capsule, Hydrochlorothiazide/
Lisinopril tablet,
Hydrochlorothiazide/Losartan
tablet, Hydrochlorothiazide/
Triamterene tab/cap, Isosorbide
Mononitrate SA tablet, Lisinopril
tablet, Losartan tablet, Metoprolol
Succinate SA tablet, Metoprolol
Tartrate tablet, Nifedipine SA
capsule, Nitroglycerin sublingual
tablet, Prazosin HCL capsule,
Propranolol HCL tablet,
Spironolactone tablet, Valsartan.
Hormones/Other.................... Alendronate tablet.
Mental Health..................... Amitriptyline HCL tablet, Buspirone
HCL tablet, Bupropion HCL tablet,
Bupropion HCL SA (12 hour-SR)
tablet, Bupropion HCL SA (24 hour-
XL) tablet, Citalopram Hydrobromide
tablet, Duloxetine HCL EC capsule,
Fluoxetine tablet/capsule,
Memantine, Mirtazapine tablet,
Paroxetine tablet, Quetiapine
Immediate Relief (IR) Tablet,
Sertraline HCL tablet, Trazodone
tablet, Venlafaxine HCL IR tablet,
Venlafaxine HCL SA capsule.
Neurologic Disorders.............. Ropinirole tablet.
Respiratory Condition............. Montelukast Sodium tablet.
Seizures.......................... Gabapentin capsule, Lamotrigine
tablet, Topiramate tablet.
Thyroid Conditions................ Levothyroxine Sodium tablet.
Urologic (Bladder and Prostate) Doxazosin Mesylate tablet,
Health. Finasteride tablet, Oxybutynin
Chloride IR tablet, Oxybutynin
Chloride SA tablet, Sildenafil
tablet, Tadalafil tablet,
Tamsulosin HCL capsule, Terazosin
HCL capsule.
------------------------------------------------------------------------
Signing Authority: Douglas A. Collins, Secretary of Veterans
Affairs, approved and signed this document on February 18, 2025, and
authorized the undersigned to sign and submit the document to the
Office of the Federal Register for publication electronically as an
official document of the Department of Veterans Affairs.
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy & Management, Office of
General Counsel, Department of Veterans Affairs.
[FR Doc. 2025-03845 Filed 3-10-25; 8:45 am]
BILLING CODE 8320-01-P
</pre></body>
</html>Indexed from Federal Register on March 11, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.